• Biological Agents for Patients With Rheumatoid Arthritis Who Had Failed Treatment With Methotrexate In The Spanish Clinical Setting- A Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • A Multivariate Safety and Efficacy Analysis of Prescribing Information for Next Generation SGLT-2 Inhibitors in Type 2 Diabetes Treatment

    Nov 1, 2015, 00:00

  • Indirect Comparison of Onabotulinum Vs. Oral Triptans for The Phrophylaxis Treatment of Chronic Migraine

    Nov 1, 2015, 00:00

  • Overall Survival (Os), Quality Of Life (Qol), And Neurocognitive Function (Nf) In Recurrent Glioblastoma Multiforme (Gbm)- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Assessment of Complementary and Alternative Medicine Use In Hepatitis-C Patients In Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Real-World Identification Of European Patients With Statin-Associated Symptoms- Clinical Practice Compared With Clinical Guidelines

    Nov 1, 2015, 00:00

  • Patient-Reported Frequency and Burden of Hypoglycaemia for Insulin-Treated Diabetes Patients In 5 Cities of China- A Cross-Section Study

    Nov 1, 2015, 00:00

  • Price Structure Assessment of Selected Oncology Products in China, Taiwan, South Korea, Brazil, and Mexico

    Nov 1, 2015, 00:00

  • Use of Complementary And Alternative Medicines (Cam) In Diabetics Patients In Quetta

    Nov 1, 2015, 00:00

  • An Assesment Of Enoxaparine Benefit On Healthcare Budget In Spain

    Nov 1, 2015, 00:00

  • Recommendations and Reimbursement Status of Orphan Drugs In Ue Countries

    Nov 1, 2015, 00:00

  • Literature Review Of Economic Evaluations Of Screening Tests For Breast Cancer

    Nov 1, 2015, 00:00

  • Effects Of Clinical Computing Systems During Consultations On Smoking Cessation - Evidence Landscape From Randomized And Quasi Randomized Trials

    Nov 1, 2015, 00:00

  • A Review of Cost Effectiveness Studies of Rheumatoid Arthritis (Ra) Interventions In The Uk And Us

    Nov 1, 2015, 00:00

  • Comparative Efficacy Of Treatments For Previously Treated Advanced Or Metastatic Non-Small Cell Lung Cancer (Nsclc)- A Network Meta-Analysis

    Nov 1, 2015, 00:00

  • Economic Evaluation of Tocilizumab Combination in the Treatment of the patients with Dmard-Ir Rheumatoid Arthritis in China

    Nov 1, 2015, 00:00

  • Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies- A Canadian Retrospective Claims Analysis

    Nov 1, 2015, 00:00

  • Body Image and Sexual Problem in Young Breast Cancer Patients in South Indian Population

    Nov 1, 2015, 00:00

  • Cost of Type 2 Diabetes According to Glucose-Lowering Medications in France

    Nov 1, 2015, 00:00

  • Patient Behaviour As A Cost Driver In The Management of Chronic Disease Patients

    Nov 1, 2015, 00:00

  • Costs of Illness of Multiple Sclerosis In Sweden – A Population-Based Register Study

    Nov 1, 2015, 00:00

  • Budget Impact Model (Bim) Of Rivaroxaban In Comparison With Enoxaparin Plus Warfarin In The Treatment Of Venous Thromboembolism (Vte) Under The Perspective Of The Private Health System

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Fingolimod Versus Dimethyl Fumarate As A Second-Line Disease Modifying Treatment In Patients With Highly Active Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Trends of Implementation of Hta In Kazakhstan

    Nov 1, 2015, 00:00

  • Cost-Effectiveness and Cost-Utility of Home-Based Hypnotherapy Using Compact Disc Versus Individual Hypnotherapy By A Therapist for Pediatric Irritable Bowel Syndrome and Functional Abdominal Pain (Syndrome)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Idelalisib Plus Rituximab In Chronic Lymphocytic Leukaemia

    Nov 1, 2015, 00:00

  • Qualitative Assessment of Societal Preferences for Market Access of Cancer Drugs

    Nov 1, 2015, 00:00

  • The Current Landscape And Expected Changes In Formulary Management

    Nov 1, 2015, 00:00

  • Patients’ choice of providers as a signal of quality of care. Evidence of twelve public hospitals in the province of buenos aires, argentina

    Nov 1, 2015, 00:00

  • Medical Devices- Why Do Some Pay More Than Others Do? Analysis Of Price Variation In French Public Hospital In 2013

    Nov 1, 2015, 00:00

  • Burden of Spinal Diseases- Results From Register Study In Sweden

    Nov 1, 2015, 00:00

  • Clinical And Economic Impact Of The Implementation Of Hpv 16/18 Genotyping Test For Cervical Cancer Screening In Mexican Healthcare System

    Nov 1, 2015, 00:00

  • Adherence and Persistence among Patients Treated with First-Line Therapies for Relapsing-Remitting Multiple Sclerosis in Brazil

    Nov 1, 2015, 00:00

  • The Impact Of Self-Monitoring Of Blood Glucose (Smbg) On Prescription Costs In Newly Treated Type 2 Diabetes Melitus (T2dm)- A Retrospective Cohort Analysis

    Nov 1, 2015, 00:00

  • Quality of Life Among Hiv Patients- Results from the Ianua Clinical Trial

    Nov 1, 2015, 00:00

  • Costo De Diabetes Mellitus No Complicada En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00

  • Budget Impact of Golimumab iv for Rheumatoid Arthritis in the Chilean Private Sector

    Nov 1, 2015, 00:00

  • Factors Influencing Treatment Duration In Metastatic Colorectic Cancer Patients Treated With Ziv-Aflibercept- A Real World View

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Delayed-Release Dimethyl Fumerate For The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal

    Nov 1, 2015, 00:00

  • The Management and Costs of Locally Advanced or Metastatic Alk-Positive Non-Small Cell Lung Cancer in Greece

    Nov 1, 2015, 00:00

  • The Impact of Biologic Therapy Versus Conventional Treatment on The Costs of Ankylosing Spondylitis Chronic Complications Under The Perspective of Brazilian Private Health Care System

    Nov 1, 2015, 00:00

  • Cost-Utility and Budget Impact Analyses Comparing Lurasidone with Aripiprazole in Adults with Schizophrenia in Scotland

    Nov 1, 2015, 00:00

  • Descriptive Evalaution of Characteristics of Patients Diagnosed with Relapsing Remitting Multiple Sclerosis and Taking Disease Modifying Agents

    Nov 1, 2015, 00:00

  • Direct Cost of Uncomplicated Hypothyroidism During Pregnancy and Childbed in Czech Republic

    Nov 1, 2015, 00:00

  • Association Between Knowledge and Medication Adherence In Patients With Type 2 Diabetes Mellitus In Pakistan

    Nov 1, 2015, 00:00

  • Potential Public Resource Savings In Brazil- The Somatropin Case

    Nov 1, 2015, 00:00

  • Medication-Taking Behaviour in Women with Postmenopausal Osteoporosis (Op) Treated with Denosumab or Monthly Oral Bisphosphonates (Obps)

    Nov 1, 2015, 00:00

  • Self-Reported Rheumatic Diseases and Early Retirement in Portugal

    Nov 1, 2015, 00:00

  • Health Proffessionals Involvement In Politics A Means to Improving Healthcare Delivery and Healthcare Legislations for Healthcare Seekers In Africa

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Proton Pump Inhibitor Initiation Aimed to Prevent Upper Gastrointestinal Toxicity in Patients Using Low-Dose Acetylsalicylic Acid

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Directly Mailed Fobt Kits To Previous Responders Being Recalled For Screening

    Nov 1, 2015, 00:00

  • Prescription Pattern Of Antihypertensive Agents In A Tertiary Care Teaching Hospital In Central Nepal

    Nov 1, 2015, 00:00

  • Patient Preferences Concerning Alternative Net Treatment Options – The Piano-Study

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life In Patients With Transthyretin Familial Amyloid Polyneuropathy

    Nov 1, 2015, 00:00

  • Nub Status – An Analysis Comparing Results of 2015 Vs. 2014 - Leading Therapeutic Areas Confirmed

    Nov 1, 2015, 00:00

  • Potential Health And Economic Impact Of Introducing A Dengue Vaccine In Malaysia- Assessment Using Dynamic Transmission Modelling

    Nov 1, 2015, 00:00

  • How Important Is The Time Factor? Saving Lives Using Fire And Rescue Services

    Nov 1, 2015, 00:00

  • Economic Analysis Of Epicup, An Epigenetic Test To Predict The Tissue Of Origin In Cancer Of Unknown Primary Site, The Usa Payors Perspective

    Nov 1, 2015, 00:00

  • Network Meta-Analysis Of Multiple Outcomes Incorporating Dose-Related Constraints- Application To Overactive Bladder Syndrome

    Nov 1, 2015, 00:00

  • Cost-Effectiveness In The Second-Line Treatment Of Non-Small Cell Lung Cancer (Nsclc) In The Us

    Nov 1, 2015, 00:00

  • Key Drivers of Cost Effectiveness In Crohn’s Disease

    Nov 1, 2015, 00:00

  • A Cost Analysis Of Open Spina Bifida Detection In The First-Trimester

    Nov 1, 2015, 00:00

  • Treatment Patterns Among Front-Line Glioblastoma Patients In Five European Countries

    Nov 1, 2015, 00:00

  • The Effectiveness and Cost-Effectiveness of Hylan G-F 20 in Osteoarthritis of the Knee

    Nov 1, 2015, 00:00

  • Cost Effectiveness Of Cetuximab In First Line Treatment Of Ras Wild-Type Metastatic Colorectal Cancer In The Uk- A Summary Of Economic Analyses Submitted To The National Institute For Health And Care Excellence (Nice)

    Nov 1, 2015, 00:00

  • Challenges Along The Road to Universal Health Coverage In Egypt, An Hio Perspective

    Nov 1, 2015, 00:00

  • How much is spent in vaccines across western europe countries?

    Nov 1, 2015, 00:00

  • Systematic Review Of Thermal Massage Therapy For The Treatment Of Dry Eye Syndrome

    Nov 1, 2015, 00:00

  • Estudio de La Implementacion de la Exigencia de Bioequivalencia Sobre el Consumo de Medicamentos Durante Agosto 2009 a Noviembre 2014 en Chile

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Fluticasone Propionate/Formoterol Fumarate (Flutiform®) Vs Fluticasone/Salmeterol And Budesonide/Formoterol In Spain

    Nov 1, 2015, 00:00

  • Exploratory Analysis of Apac Values Versus Recommended Treatment Guidelines For Metastatic Non-Small Cell Lung Cancer (Mnsclc) In The Brazilian Public Healthcare System

    Nov 1, 2015, 00:00

  • The Importance of Inhaler Devices- An Incorrect Inhaler Technique Leads to Suboptimal Medication Compliance In Patients With Copd

    Nov 1, 2015, 00:00

  • Willingness To Pay For Improved Clinical Outcomes And Reduced Treatment Burden Associated With Insulin Treatment In People With Type 2 Diabetes In South America

    Nov 1, 2015, 00:00

  • Cost-Utility Of Statin In Secondary Prevention- A Propensity Score Method Of Administrative Database

    Nov 1, 2015, 00:00

  • Systematic Litertaure Review Of Direct Health Care Costs For Cardiovascular Events Among European Patients With Dyslipidemia Or High Cardiovascular Risk

    Nov 1, 2015, 00:00

  • Off-Patent Drugs Consumption And Expenditures In Italy- 2009-2013

    Nov 1, 2015, 00:00

  • Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Prostate Cancer

    Nov 1, 2015, 00:00

  • Assessing The Treatment of Peripheral Neuropathic Pain (Pnep) And Postherpetic Neuralgia (Phn) In China Using A Simulation Model

    Nov 1, 2015, 00:00

  • Cholera Death Audit In Ghana- A Medical Record Review of The 2014 Outbreak

    Nov 1, 2015, 00:00

  • Systematic Review On The Correlation Between Lung Function Or Eosinophil Levels And Quality Of Life In Asthma

    Nov 1, 2015, 00:00

  • Results Of A Dutch Cost-Effectiveness Model Of Radium-223 In Comparison To Cabazitaxel, Abiraterone, And Enzalutamide In Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Docetaxel

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Everolimus In Liver Transplantation

    Nov 1, 2015, 00:00

  • Correlation of Triglycerides and Acute Pancreatitis- a Systematic Evidence Review

    Nov 1, 2015, 00:00

  • Analisis De Costo Efectividad Del Diagnostico De La Distrofia Muscular De Duchenne O Becker En Colombia

    Nov 1, 2015, 00:00

  • Modeling The Natural History of Secondary-Progressive Multiple Sclerosis- A New Modeling Approach Using Discrete Event Simulation

    Nov 1, 2015, 00:00

  • Pen Devices for Insulin Administration Compared to Needle And Vial- Systematic Review of Literature and Meta-Analysis

    Nov 1, 2015, 00:00

  • Overall Survival (Os) And Quality-Of-Life (Qol) Outcomes In Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck (Scchn)- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Adherence to Initiated Basal Insulin Analog Treatment In Type 1 and 2 Diabetes

    Nov 1, 2015, 00:00

  • Examining The Economic Impact of Laboratory Developed Testing In Flow Cytometry Immunophenotyping for Hematologic Malignancies- An Analysis of Health Resource Utilization

    Nov 1, 2015, 00:00

  • Lead Damage in the First-Year Following Cardiac Implantable Electronic Device (Cied) Replacement- Incidence and Costs Based on Device Type

    Nov 1, 2015, 00:00

  • How Useful are Eq-5d And Zbi In Assessing The Impact of Caring for Alzheimer’s Disease Patients?

    Nov 1, 2015, 00:00

  • Modeling Of Risks And Benefits Of Lung Cancer Screening Strategies Using Low-Dose Helical Ct (Ldct) Technology In Canada

    Nov 1, 2015, 00:00

  • Healthcare Resource Utilization Costs Related to Anaemia Management In Chronic Kidney Disease Non-Dialysed Patients- A Retrospective Clinical and Administrative Database Analysis

    Nov 1, 2015, 00:00

  • Glaucoma- Highlight Molecules Used In Patients From Supplementary Health In Brazil

    Nov 1, 2015, 00:00

  • Comparative Effectiveness and Cost-Effectiveness of Generic Alendronate, Risendronate, Denosumab and Zolendronic Acid for Secondary Prevention of Fragility Fractures - Perliminay Results

    Nov 1, 2015, 00:00

  • Impact of A Payment By Results Access Scheme In Italy- Better Value For Money?

    Nov 1, 2015, 00:00

  • Retrospective Cohort Study Using Data From The Uk Clinical Practice Research Datalink and Hospital Episode Statistics to Assess Unplanned Hospitalisation In Patients With Multiple Myeloma

    Nov 1, 2015, 00:00

  • Assessment Of Major Molecular Response (Mmr) And Complete Cytogenetic Response (Ccyr) As Surrogate Outcomes Of Survival In Chronic Myeloid Leukemia Chronic Phase (Cml-Cp) Patients

    Nov 1, 2015, 00:00

  • Development Of A Conceptual Model For Early Health Technology Assessment Of Tissue-Engineered Heart Valves

    Nov 1, 2015, 00:00

  • What Do we Mean When we Talk About “U.S. Spanish”?

    Nov 1, 2015, 00:00

  • Relationship Between Community Pharmacy Attribution And Patient’s Outcomes In Healthcare Service of Home-Visiting

    Nov 1, 2015, 00:00

  • Resource Utilization In Patients With Advanced Melanoma In France

    Nov 1, 2015, 00:00

  • A Conceptual Search Filter to Identify Real-World Evidence

    Nov 1, 2015, 00:00

  • Associations Of Metformin Use With Mortality And Disease Progression After Curative Hepatic Resection In Hepatocellular Carcinoma With Type 2 Diabetes Mellitus- A Nationwide Population-Based Study

    Nov 1, 2015, 00:00

  • Systematic Review of Compliance to Bisphosphonates in Patients with Osteoporosis in Rct and Real Practice

    Nov 1, 2015, 00:00

  • Evaluation of The Cost Effectiveness and Societal Impact of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In The Netherlands

    Nov 1, 2015, 00:00

  • A Study on Health Care Professional’s Sense of Ethics In Japan

    Nov 1, 2015, 00:00

  • Lagrange Method for Budget Optimization Analysis in Resource Allocation for Antipsychotic Therapies in Colombia

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales

    Nov 1, 2015, 00:00

  • Measurement of the burden, resources use and health costs associated with herpes zoster and post-herpetic neuralgia in mexico. Master study

    Nov 1, 2015, 00:00

  • Standardization Process Of Raw Datasus And Consumption Analysis Of Oncology Therapies In The Brazil Public Health Care System- A Comparison Between Raw And Standardized Dataset In Colorectal And Lung Cancer

    Nov 1, 2015, 00:00

  • Different Models For Different Payers – Are We Moving Towards Or Away From Universal Economic Models?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Screening for Colorectal Cancer In Argentina

    Nov 1, 2015, 00:00

  • Outcome Research to Investigate The Actual Status of Mrsa Infection And Usage of Anti-Mrsa Drugs In Real Clinical Settings In Japan - A Retrospective Database Study

    Nov 1, 2015, 00:00

  • Health Related Quality of Life In Patients With Diabetic Foot Ulceration – Observational Study In Poland

    Nov 1, 2015, 00:00

  • Clinical And Economic Impacts Of The Use Of A Prescription Assistance Software For Vitamin K Antagonist Treatment In French Management Of Atrial Fibrillation And Venous Thromboembolic Events

    Nov 1, 2015, 00:00

  • Analysis Of Eribulin Mesylate Dosing Modifications Impact On Administration Persistence In Patients With Metastatic Breast Cancer (Mbc)

    Nov 1, 2015, 00:00

  • Bayesian Network Meta-Analysis (NMA) to Assess the Relative Efficacy of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Insulin

    Nov 1, 2015, 00:00

  • The Prostate Cancer Registry- Analysis of Medical Resource Utilisation (Mru) in An International, Prospective, Observational Study of Men with Metastatic Castration-Resistant Prostate Cancer (Mcrpc)

    Nov 1, 2015, 00:00

  • Methotrexate Adherence Questionnaire- a New Tool to Assess Adherence in Patients Treated with Methotrexate

    Nov 1, 2015, 00:00

  • Does Treatment Adherence Correlates With Health-Related Quality of Life- Findings From A Cross Sectional Analysis of Type 2 Diabetes Mellitus Patients In Pakistan

    Nov 1, 2015, 00:00

  • Investigating The Cost-Effectiveness Of Bacterial Whole-Genome Sequencing For Enabling Targeted Antibiotic Selection In Urinary Tract Infections

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of Aripiprazole Once-Monthly Versus Paliperidone Palmitate in the UK- Findings From Qualify

    Nov 1, 2015, 00:00

  • Identifying The Most Cost-Effective Way of Diagnosing Asthma In Adults Using Multiple Tests – A Cost-Utility Analysis From The Nice Asthma Guideline

    Nov 1, 2015, 00:00

  • Health Care Policy and Cost After Earthquake In Nepal

    Nov 1, 2015, 00:00

  • Abstract Title- Descriptive Evaluation of Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Malignant Neoplasm of Rectum

    Nov 1, 2015, 00:00

  • Identification Of Subgroups With Low Rates Of Smoking Cessation In Israel

    Nov 1, 2015, 00:00

  • Differences in Price of Medicines Available from Pharmaceutical Companies and “Jan Aushadhi” Stores

    Nov 1, 2015, 00:00

  • Costs to U.S. Health Insurers for Hematopoietic Stem Cell Transplant (Hct) Recipients with Double Stranded Dna (Dsdna) Virus Infections Following Transplant

    Nov 1, 2015, 00:00

  • Verification and Validation of Health Economic Models for Diabetes

    Nov 1, 2015, 00:00

  • Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy

    Nov 1, 2015, 00:00

  • Assessing The Impact of Growth Hormone Deficiency (Ghd) In Children- Concept Elicitation Results Supporting The Development of The Treatment-Related Impact Measure for Childhood Ghd (Trim-Cghd)

    Nov 1, 2015, 00:00

  • Costs of Absenteeism In Psoriatic and Enteropathic Arthropathies Based on Real-Life Data From Poland’s Social Insurance Institution Database In 2013

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Pneumococcal Vaccination of Elderly In Germany

    Nov 1, 2015, 00:00

  • Trends In Health Technology Assessment Decisions Across The Globe- A Focus on Hepatitis C

    Nov 1, 2015, 00:00

  • Consumer Interest in Adopting an Electronic Health Record (EHR) Mobile Application Based on the Risk that Identifiable Information is Leaked

    Nov 1, 2015, 00:00

  • Effectiveness of Allopurinol In Achieving And Sustaining Target Serum Urate- An Analysis of A National Integrated U.S. Healthcare System

    Nov 1, 2015, 00:00

  • How To Conduct Economic Evaluations Of New Treatments For Advanced Cancer When Overall Survival Data Are Not Available? Results From A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Cost of Adverse Drug Events on Health Resources Utilizaton in Older Adult Singaporeans

    Nov 1, 2015, 00:00

  • A Participação do Departamento de Ciência e Tecnologia do Ministério da Saúde Na Revisão e Atualização da Rename

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Study Of The Use Of Rituximab For Subcutaneous Administration In The Treatment Of Follicular Lymphoma

    Nov 1, 2015, 00:00

  • Analysis Of Evidence Data About Adding Succinic Acid To The Various Medicines

    Nov 1, 2015, 00:00

  • The Issue for Sexuality After Cervix Cancer Treatment Among Woman

    Nov 1, 2015, 00:00

  • Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu)

    Nov 1, 2015, 00:00

  • Oncology Literature Bank For Cancers And Therapies For Heor- Concept And Utilization Of Oncolitbank

    Nov 1, 2015, 00:00

  • Costos de Infección Respiratoria Aguda Grave Asociada Al Virus de La Influenza en Colombia

    Nov 1, 2015, 00:00

  • Descriptive Evaluation of Patient Characteristics and Health Care Resource Utilization of Patients Diagonsed with Malignant Neoplasm of Anus

    Nov 1, 2015, 00:00

  • Examination of the Effect of Clinical Practices among Nursing Students

    Nov 1, 2015, 00:00

  • Economic Benefits Associated With Nt-Probnp Test In Brazil and Mexico

    Nov 1, 2015, 00:00

  • Discount Distribution Analysis of Original Medicines Which Has No Generics In Turkey

    Nov 1, 2015, 00:00

  • Elderly Osteoporosis Suspects without Diagnosis – Interim Data from a German Geriatric Practice

    Nov 1, 2015, 00:00

  • Filling the Gap Between Risk/Benefit Assessment for Drugs and Risk Assessment for Consumer Goods

    Nov 1, 2015, 00:00

  • Burden of Anemia Among Indian Women- A Systematic Review And Meta-Analysis of Literature

    Nov 1, 2015, 00:00

  • Peculiarity, Environmental and Chronic Diseases- Using Ecological Models as a Framework for Analysising Risk Factors of Chronic Diseases

    Nov 1, 2015, 00:00

  • Use of Economic Evaluations of Health Technologies In Dutch Healthcare Decision-Making- Barriers And Facilitators

    Nov 1, 2015, 00:00

  • Association Between Adherence to Evidence-Based Heart Failure Drug Treatment and One-Year All-Cause Hospitalization and All-Cause Mortality

    Nov 1, 2015, 00:00

  • The Influence of “Has” Haute Autorite De Sante In The Reimbursement Decisions In Francophone Countries- The Case of North Africa Region

    Nov 1, 2015, 00:00

  • Efficacy Comparison of Anti-Vegf and Laser Photocoagulation in the Treatment of Visual Impairment due to Diabetic Macular Edema- a Systematic Review and Network Meta-Analysis

    Nov 1, 2015, 00:00

  • Risk Factors For Dementia Diagnosis In German Primary Care Practices

    Nov 1, 2015, 00:00

  • The Use of Interquartile Deviation in Establishing Delphi Panel Consensus- A Prioritization of Intravenous Immunoglobulin Utilization

    Nov 1, 2015, 00:00

  • Impact of The Changes In The Portuguese Pharmacy Remuneration System

    Nov 1, 2015, 00:00

  • Development, Test-Retest Reliability And Validity of the Pharmacy Value Added Services Questionnaire

    Nov 1, 2015, 00:00

  • Real World Data On Colony-Stimulating Factors (Csf) In Oncology- Patterns Of Use In Brazil

    Nov 1, 2015, 00:00

  • Performance Score Extraction from Panel Data for Multi-Criteria Decision Analysis (Mcda) Using a Regression-Based Approach

    Nov 1, 2015, 00:00

  • Burden of Cost in Bronchiolitis Obliterans Syndrome (Bos)- Predictions for the Next Decade

    Nov 1, 2015, 00:00

  • Systematic Review and Mixed Treatment Comparison of Therapies for Diabetic Macular Edema

    Nov 1, 2015, 00:00

  • The Acceptance Of Morbidity Endpoints In The Amnog Process In Germany- Are There Greater Hurdles For Substances Within Oncology?

    Nov 1, 2015, 00:00

  • Trends of Research Related Brazil Published in Ispor Meetings- A Bibliometric Analysis from 1998 to 2014

    Nov 1, 2015, 00:00

  • Investigating The Value of Patient Level Data to Inform Estimates of Adpkd Progression Generated Within The Adpkd Outcomes Model

    Nov 1, 2015, 00:00

  • Alternative Regression Methods For Mapping Utilities In Oncology

    Nov 1, 2015, 00:00

  • Development Of An International Observational Study Programme To Describe The Management And Outcomes Of Mild Stroke And Transient Ischaemic Attack In Routine Clinical Practice

    Nov 1, 2015, 00:00

  • Análisis de Visiones y Percepciones de Potenciales Beneficiarios de la Institucionalización de un Proceso de Evaluación de Tecnologías Sanitarias En Chile- un Estudio Cualitativo

    Nov 1, 2015, 00:00

  • Impact of A Telephonic Outreach Program on Medication Adherence In Medicare Advantage Prescription Drug (Mapd) Plan Beneficiaries

    Nov 1, 2015, 00:00

  • An Eq-5d-5l Value Set Based On Uruguayan Population Preferences- Report Of The First Experience In Latin America

    Nov 1, 2015, 00:00

  • Decontamination and Infection Control of Nursing Tools and Patient Environment Regarding Nosocomialis Infections

    Nov 1, 2015, 00:00

  • The Impact of Robotic Technology on Neuro-Rehabilitation- Preliminary Results on Acceptability And Effectiveness

    Nov 1, 2015, 00:00

  • Impact Of Heart Failure On Hospital Admissions And Mortality In Spain In The Period 2009-2013

    Nov 1, 2015, 00:00

  • Unique Device Identifier System- The Impact Of The Portuguese Experience

    Nov 1, 2015, 00:00

  • Análisis Costo-Utilidad Del Manejo Integral De Las Pacientes Con Carcinoma De Seno Tratadas Con Reconstruccion De Seno Inmediata Vs. Diferida En Colombia

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of First-Line Tyrosine Kinase Inhibitors (Tkis) In Newly Diagnosed Chronic Myeloid Leukemia (Cml) Patients In Korea- Comparison Of Dasatinib (100mg), Nilotinib (600mg) And Imatinib (400mg)

    Nov 1, 2015, 00:00

  • Assessment of Compliance and Avoided Costs After Implementation of Equivalent Terapeutic Program for Candida Infection Treatment

    Nov 1, 2015, 00:00

  • Development Of Prescription E-Protocols For Medicines And Integration On The Greek National E-Prescription System

    Nov 1, 2015, 00:00

  • Does The Legal Regulation Of Promoting Pharmaceutical Parallel Imports Helps To Create Savings For The Statutory Health Insurance (Gkv) In Germany?

    Nov 1, 2015, 00:00

  • Health-Economic Analysis of The Use of Sensor-Augmented Pump (Sap) Therapy In The Netherlands Compared to Insulin Pump Therapy Alone (Csii), In Type 1 Diabetic Patients

    Nov 1, 2015, 00:00

  • Análisis De Minimización De Costos Del Uso De Trastuzumab Subcutáneo Frente A Trastuzumab Intravenoso En El Tratamiento De Cáncer De Mama Temprano En Mujeres Con Her2 Positivo Para Venezuela

    Nov 1, 2015, 00:00

  • Biosimilar Substitution Policies- An Overview

    Nov 1, 2015, 00:00

  • Sensitivity Analysis In Discrete Choice Experiments For Rare Diseases – An Analysis Within The Piano-Study

    Nov 1, 2015, 00:00

  • Methodological Considerations for the Implementation of A European Mandated Retrospective Drug Utilisation Study (Dus) to Investigate the Use of Dexmedetomidine (Dexdor®) in Clinical Practice

    Nov 1, 2015, 00:00

  • Healthcare Resource Utilization Associated with Varicella in Argentina

    Nov 1, 2015, 00:00

  • A Trial-Based Economic Evaluation of Resource use and Costs in the Emilia Clinical Study

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland

    Nov 1, 2015, 00:00

  • Mixed Treatment Comparison to Rank Antiresorptive Agents In Preventing New Non Vertebral Fractures In Postmenopausal Osteoporosis

    Nov 1, 2015, 00:00

  • Adapting The Adpkd Outcomes Model to Predict Cost Consequence In Italian Patients With Autosomal Dominant Polycystic Kidney Disease (Adpkd) Treated With Jinarc (Tolvaptan)

    Nov 1, 2015, 00:00

  • The Relation Between Real Costs Of Drugs Temporarily Reimbursed In Mode Of Coverage With Evidence Development And Budget Impact Analysis Submitted As A Mandatory Requirement Of The Application

    Nov 1, 2015, 00:00

  • Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy- Observations Based on Real-World Data

    Nov 1, 2015, 00:00

  • Vivascope© For Diagnosing Melanoma- A Systematic Review

    Nov 1, 2015, 00:00

  • Identifying Current Treatment Practices In Non-Hodgkin’s Lymphoma

    Nov 1, 2015, 00:00

  • Trastuzumab Emtansine for Her2 Positive Breast Cancer Patients- an Updated Systematic Review

    Nov 1, 2015, 00:00

  • The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland- a Comparison Between the use of Denosumab and Zoledronic Acid In Patients with Prostate Cancer And Bone M ...

    Nov 1, 2015, 00:00

  • The Effect of Stress and Coping Resources on Predicting Quality of Life of Graduate Students

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of 18f-Fdg Pet/Ct for Screening Distant Metastasis in Stage Ii/Iii Breast Cancer Patients of the UK, the United States and the Netherlands

    Nov 1, 2015, 00:00

  • “First And Foremost Battle The Virus” - Patient Preferences In Antiviral Therapy For Hepatitis C

    Nov 1, 2015, 00:00

  • Assessment of Drug Prescribing Among Pregnant Women Attending Antenatal Out Patient Department of A Referral Hospital In Ethiopia

    Nov 1, 2015, 00:00

  • Multiple Use Of Antibiotic In Post Operative Patients In Tertiary Care Hospital Of Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Direct Medical Costs Associated with Multiple Myeloma in Chinese Patients- Estimations from China Public Health Insurance Claim Data

    Nov 1, 2015, 00:00

  • Access Inequalities between Private and Public Insurance Among Cancer Patients- Results of a National Survey in Brazil

    Nov 1, 2015, 00:00

  • Loss Of Opportunity Linked With The Suboptimal Coverage Rate Of Hpv Vaccination In France

    Nov 1, 2015, 00:00

  • Trends Of Sick-Pay Benefits In Hungary Between 2005-2013

    Nov 1, 2015, 00:00

  • Structured Review Of Patient Quality Of Life Following Diagnosis With Prostate Cancer

    Nov 1, 2015, 00:00

  • Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin for Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Saudi Arabia

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life In Double-Blind Phase Iii Studies of Brivaracetam As Adjunctive Therapy of Partial-Onset Seizures

    Nov 1, 2015, 00:00

  • Satisfaction with life of general population of pakistan. A nation wide survey

    Nov 1, 2015, 00:00

  • Primary Care Dementia Clinic Reduces Societal Cost of Dementia- A Cost-Utility Analysis

    Nov 1, 2015, 00:00

  • Identifying Opportunities For Value-Based Contracting For Molecular Diagnostics As A Means To Improve Outcomes Of Hospital Acquired Infections

    Nov 1, 2015, 00:00

  • Clinical, Mediciation and Economical Outcome Research of Advanced Colorectal Cancer Relapse Using Reimbursement and Cancer Registry Databases

    Nov 1, 2015, 00:00

  • Prevalence, Comorbidities and Burden of Severe Spondyloarthritis In Fran Analysis of A National Public Health Insurance Database In 2012 In France

    Nov 1, 2015, 00:00

  • A Cost-Utility Analysis of Different Oral Antiviral Medications In Patients With Chronic Hepatitis B In Iran- An Economic Micro-Simulation Decision Model

    Nov 1, 2015, 00:00

  • The Futility of Cost-Efficacy Analysis

    Nov 1, 2015, 00:00

  • A Pilot Study of Direct Costs for Patients With Rheumatoid Arthritis In Bulgaria

    Nov 1, 2015, 00:00

  • Análisis de costo-efectividad de la warfarina vs. Dabigatrán etexilato en fibrilación auricular en ecuador

    Nov 1, 2015, 00:00

  • The Eu Patient Registry Landscape- Survey of Registry Profiles Through Parent Ja Research And Framework

    Nov 1, 2015, 00:00

  • Success Rate of Including Medicines to The Reimbursement System In Slovakia

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis Of Enzalutamide For Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (Mcrpc) After Failure Of Androgen Deprivation Therapy (Adt)

    Nov 1, 2015, 00:00

  • Stapled Haemorrhoidopexy To Treat Hemorrhoids Grade Iii And Iv- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • Comparison Of Treatment Duration Among Targeted Agents In Renal Cell Carcinoma (Rcc)

    Nov 1, 2015, 00:00

  • Better Reimbursement Decision-Making Based on Expected Cost-Effectiveness- Using Value of Information Decision Analysis to Improve The Design and Efficacy of A Phase Iii Program for Erlotinib

    Nov 1, 2015, 00:00

  • Evaluación Costo-Utilidad De Dos Alternativas De Vacunación Para El Virus Del Papiloma Humano (Vph) En La Prevención Del Cancer Cervical Uterino

    Nov 1, 2015, 00:00

  • Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us)

    Nov 1, 2015, 00:00

  • Join Progress A Efficiency Partnership Program on Knee Joint Replacement

    Nov 1, 2015, 00:00

  • Rates of Adverse Events and Multiple Sclerosis Relapses Before and After Introduction of a Purported Generic Glatiramer Acetate in mexico- Results from a Large Patient Support Program in Mexico

    Nov 1, 2015, 00:00

  • Costo – Efectividad De Apixaban Con Otros Noacs (Dabigatran Y Rivaroxaban) En El Tratamiento De La Fibrilacion Auricular No Valvular (Fanv) En Pacientes De La Seguridad Social De Perú

    Nov 1, 2015, 00:00

  • Natalizumab Use In Multiple Sclerosis- A Real World Evidence (Rwe) Analysis of Its Impact on Nhs Resources In England

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis For Cervical Cancer Screening Using Hpv Tests In Chile

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Study On The Increased Intake Of Potassium And Vitamin B2 Among Adults In China

    Nov 1, 2015, 00:00

  • Treatment Strategies, Health Care Resource use and Costs of Aggressive Histological types of non-Hodgkin Lymphomas in the Slovak Republic. Results from the Cross-Sectional Survey in the Haematology-Oncological Centers

    Nov 1, 2015, 00:00

  • Analysis Of Primary And Secondary Apr-Drg Codes Of An Ischemic Stroke Admission

    Nov 1, 2015, 00:00

  • Translatability Assessment and Linguistic Validation of The Patient-Reported Outcome Instrument for Irritable Bowel Syndrome With Diarrhea (Ibs-D Pro)

    Nov 1, 2015, 00:00

  • Clinical Multi-Criteria Decision Assessment (Cmda)- A Proposal for Applying Mcda to Compare Treatments in a Simultaneous, Transparent and Overall Way

    Nov 1, 2015, 00:00

  • Economic Burden in Studies Published in 2014- What Type of Mental Health Disorders and Outcomes Have Been Most Commonly Assessed?

    Nov 1, 2015, 00:00

  • Therapeutic Reference Pricing System In Slovenia From The Patients’ Perspective

    Nov 1, 2015, 00:00

  • Ten Years of The International Pompe Survey- Patient Reported Outcomes As A Reliable Tool for Studying Treated and Untreated Children and Adults With Non-Classic Pompe Disease

    Nov 1, 2015, 00:00

  • Eroltinib Plus Gemcitabine Compared With Gemcitabine Monotherapy In Patients With Pancreatic Cancer- A Real-World Analysis Of Korean Nationa-Wide Database

    Nov 1, 2015, 00:00

  • Bayesian Network Meta-Analysis To Assess Relative Efficacy Of Ibrutinib Versus Idelalisib+Ofatumumab And Physician’s Choice In Relapsed/Refractory Cll Patients

    Nov 1, 2015, 00:00

  • Full Economic Assessment of Rotavirus Vaccination Using the Health Economic Cauliflower Toolbox

    Nov 1, 2015, 00:00

  • Regional Versus Centralized Hta- Implications for the Assessment of Cancer Drugs

    Nov 1, 2015, 00:00

  • G-Ba Does not Adjust Evidence Requirements in Early Benefit Assessment in Cases of Pre-Defined, Efficacy-Based Cross-Over Decisions in Oncology Trials

    Nov 1, 2015, 00:00

  • Basic Attitude Of Japanese Physicians Towards Healthcare Resource Allocation In A Setting Of Budget Constraints

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Tiotropium In The Treatment Of Patients With Asthma

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Health State Utilities for Adults With Type 1 Diabetes

    Nov 1, 2015, 00:00

  • Adjusting For Treatment Switching in Rcts – Identifying, Analysing and Justifying Appropriate Methods- a Case Study in Metastatic Melanoma

    Nov 1, 2015, 00:00

  • State and Prospects of Pharmacoeconomics Training in Ukraine

    Nov 1, 2015, 00:00

  • The Power of the Patient Voi Formalising Qualitative Data in the Drug Approval Process

    Nov 1, 2015, 00:00

  • La Hipoglucemia Incrementa El Gasto En Salud Y Deteriora La Productividad De Pacientes Con Diabetes Tipo 1 Y Tipo 2

    Nov 1, 2015, 00:00

  • Budget Impact Model for Cervical Cancer Screening Using Hpv Tests In Chile

    Nov 1, 2015, 00:00

  • Effectiveness Of Supporting Informal Caregivers Of People With Dementia- A Systematic Review

    Nov 1, 2015, 00:00

  • Budget Impact Analysis In The Uk Setting – Know Your Audience

    Nov 1, 2015, 00:00

  • The Economic Consequences of the use of Antidepressants in Belgium- Prescribing Behavior and Misuse of Antidepressants

    Nov 1, 2015, 00:00

  • Biopharma Intervention Valuation- An Evidence-Based Appraisal Framework for Oncology Drugs

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Or 4 Chronic Hepatitis C in England and Wales

    Nov 1, 2015, 00:00

  • Inadequate Treatment of Post-Surgical Pain May Result in Extended Hospitalization Period

    Nov 1, 2015, 00:00

  • Humanistic Burden of Chronic Spontaneous Urticaria in Comparison to Psoriasis- European Perspective

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis Of Apixaban In The Acute Treatment And Prevention Of Venous Thromboembolism In France

    Nov 1, 2015, 00:00

  • A Study on Cytogenetic Analyses and Mecp2 Mutation With Dopamine And Serotonin In Rett Syndrome (Rtt)

    Nov 1, 2015, 00:00

  • Health And Economic Outcomes Related to Delay Between Medical Indication and Treatment With Ranibizumab In Age-Related Macular Degeneration In Greece

    Nov 1, 2015, 00:00

  • Does The Atu Process Have An Impact On Time To Market Launch?

    Nov 1, 2015, 00:00

  • Incorporation Of Evidence Based Medicine Into The European Observatory On Health Systems And Policies Document Describing The Health Systems Of Countries Not Belonging To The European Union

    Nov 1, 2015, 00:00

  • Economic Considerations In Clinical Guidelines - Are Patient Perspectives Considered?

    Nov 1, 2015, 00:00

  • The Cost–Effectiveness Of Regorafenib In The Treatment Of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies In Turkey

    Nov 1, 2015, 00:00

  • Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy

    Nov 1, 2015, 00:00

  • Introducing Orange- An International Price Reference Tool

    Nov 1, 2015, 00:00

  • Economic Burden of Pneumococcal Infections In Children Under Five Years Old

    Nov 1, 2015, 00:00

  • Inclusion Of A Novel Ibs Blood Panel For Diagnosing Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)- A Uk Perspective

    Nov 1, 2015, 00:00

  • Instructions for Authors

    Sep 1, 2015, 00:00

  • Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome- Doubled Costs Compared with Patients with Asthma Alone

    Sep 1, 2015, 00:00

  • Convergence yet Continued Complexity- A Systematic Review and Critique of Health Economic Models of Relapsing-Remitting Multiple Sclerosis in the United Kingdom

    Sep 1, 2015, 00:00

  • Unifying Research and Reimbursement Decisions- Case Studies Demonstrating the Sequence of Assessment and Judgments Required

    Sep 1, 2015, 00:00

  • Copyright/Subscription

    Sep 1, 2015, 00:00

  • Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States

    Sep 1, 2015, 00:00

  • Rare Disease Terminology and Definitions—A Systematic Global Review- Report of the ISPOR Rare Disease Special Interest Group

    Sep 1, 2015, 00:00

  • Erratum

    Sep 1, 2015, 00:00

  • What Guidance are Economists Given on How to Present Economic Evaluations for Policymakers? A Systematic Review

    Sep 1, 2015, 00:00

  • Calculating Preference Weights for the Labor and Delivery Index- A Discrete Choice Experiment on Women’s Birth Experiences

    Sep 1, 2015, 00:00

  • Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom

    Sep 1, 2015, 00:00

  • Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease- A Population-Based Cohort Study in Finland

    Sep 1, 2015, 00:00

  • Clinical Outcome Assessments- Conceptual Foundation—Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force

    Sep 1, 2015, 00:00

  • Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder

    Sep 1, 2015, 00:00

  • Development and Validation of a Score for Adjusting Health Care Costs in General Practice

    Sep 1, 2015, 00:00

  • Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States

    Sep 1, 2015, 00:00

  • Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort

    Sep 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Minimally Invasive versus Open Surgery Techniques for Lumbar Spinal Fusion in Italy and the United Kingdom

    Sep 1, 2015, 00:00

  • Comparison Costs of ERCP and MRCP in Patients with Suspected Biliary Obstruction Based on a Randomized Trial

    Sep 1, 2015, 00:00

  • Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data

    Sep 1, 2015, 00:00

  • Monetary Valuation of Informal Care Based on Carers’ and Noncarers’ Preferences

    Sep 1, 2015, 00:00

  • Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF

    Sep 1, 2015, 00:00

  • Economic Evaluation of the effect of Quitting Smoking on Weight Gains- Evidence from the United Kingdom

    Sep 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom

    Sep 1, 2015, 00:00

  • ISPOR Task Force For Clinical Outcomes Assessment- Clinical Outcome Assessments- Conceptual Foundation—Report of The ISPOR Clinical Outcomes Assessment – Emerging Good Practices For Outcomes Research Task Force

    Sep 1, 2015, 00:00

  • Table of Contents

    Sep 1, 2015, 00:00

  • The iMTA Productivity Cost Questionnaire

    Sep 1, 2015, 00:00

  • Economic Evaluations in the Diagnosis and Management of Traumatic Brain Injury- A Systematic Review and Analysis of Quality

    Jul 1, 2015, 00:00

  • Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research- An ISPOR Medication Adherence and Persistence Special Interest Group Report

    Jul 1, 2015, 00:00

  • Measuring Preferences for a Diabetes Pay-for-Performance for Patient (P4P4P) Program using a Discrete Choice Experiment

    Jul 1, 2015, 00:00

  • Table of Contents

    Jul 1, 2015, 00:00

  • An Evaluation of Health Service Impacts Consequent to Switching from Brand to Generic Venlafaxine in New Zealand under Conditions of Price Neutrality

    Jul 1, 2015, 00:00

  • When Does FDAMA Section 114 Apply? Ten Case Studies

    Jul 1, 2015, 00:00

  • Why Did the Randomized Clinical Trial Become the Primary Focus of My Career?

    Jul 1, 2015, 00:00

  • Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease- Determinants and Level of Changes Observed

    Jul 1, 2015, 00:00

  • Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib Assessments

    Jul 1, 2015, 00:00

  • Investigating the Generalizability of Economic Evaluations Conducted in Italy- A Critical Review

    Jul 1, 2015, 00:00

  • Cost-Effectiveness of a Nonpharmacological Intervention in Pediatric Burn Care

    Jul 1, 2015, 00:00

  • Goal-Directed Fluid Therapy Guided by Cardiac Monitoring During High-Risk Abdominal Surgery in Adult Patients- Cost-Effectiveness Analysis of Esophageal Doppler and Arterial Pulse Pressure Waveform Analysis

    Jul 1, 2015, 00:00

  • An Analysis of the Public Financial Support Eligibility Rule for French Dependent Elders with Alzheimer’s Disease

    Jul 1, 2015, 00:00

  • The Cost-Effectiveness of Different Hearing Screening Strategies for 50- to 70-Year-Old Adults- A Markov Model

    Jul 1, 2015, 00:00

  • The Social Distribution of Health- Estimating Quality-Adjusted Life Expectancy in England

    Jul 1, 2015, 00:00

  • Extending Treatment Networks in Health Technology Assessment- How Far Should We Go?

    Jul 1, 2015, 00:00

  • Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression

    Jul 1, 2015, 00:00

  • David Sackett 1934–2015

    Jul 1, 2015, 00:00

  • The Cost-Effectiveness of Cognitive-Behavioral Group Training for Patients with Unexplained Physical Symptoms

    Jul 1, 2015, 00:00

  • Cost-Effectiveness Analysis of a Television Campaign to Promote Seasonal Influenza Vaccination Among the Elderly

    Jul 1, 2015, 00:00

  • Cost-Effectiveness of Reduced Waiting Time for Head and Neck Cancer Patients due to a Lean Process Redesign

    Jul 1, 2015, 00:00

  • HIV Rapid Testing in a VA Emergency Department Setting- Cost Analysis at 5 Years

    Jul 1, 2015, 00:00

  • A Systematic Review on the Cost-Effectiveness of Genetic and Electrocardiogram Testing for Long QT Syndrome in Infants and Young Adults

    Jul 1, 2015, 00:00

  • Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia- A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial

    Jul 1, 2015, 00:00

  • Instructions for Authors

    Jul 1, 2015, 00:00

  • Copyright/Subscription

    Jul 1, 2015, 00:00

  • Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time- Results from the Swedish Heart Failure Registry

    Jun 1, 2015, 00:00

  • Responder Definition of a Patient-Reported Outcome Instrument for Laryngopharyngeal Reflux Based on the US FDA Guidance

    Jun 1, 2015, 00:00

  • Analysis of Medicine Prices in New Zealand and 16 European Countries

    Jun 1, 2015, 00:00

  • Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy- A Delphi Survey in Belgian Stakeholders

    Jun 1, 2015, 00:00

  • Effectiveness and Content Analysis of Interventions to Enhance Oral Antidiabetic Drug Adherence in Adults with Type 2 Diabetes- Systematic Review and Meta-Analysis

    Jun 1, 2015, 00:00

  • Extracorporeal Photopheresis for Second-Line Treatment of Chronic Graft-versus-Host Diseases- Results from a Health Technology Assessment in Italy

    Jun 1, 2015, 00:00

  • Copyright/Subscription

    Jun 1, 2015, 00:00

  • The Continuing Story of the Cost-Effectiveness of Photoselective Vaporization of the Prostate versus Transuretheral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Obstruction

    Jun 1, 2015, 00:00

  • Bringing Patient-Centered Outcomes Research to Life

    Jun 1, 2015, 00:00

  • Instructions for Authors

    Jun 1, 2015, 00:00

  • A Systematic Review of Research Guidelines in Decision-Analytic Modeling

    Jun 1, 2015, 00:00

  • The Lifetime Economic Burden of Inaccurate HER2 Testing- Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer

    Jun 1, 2015, 00:00

  • Economics of the Iceberg- Informal Care Provided to French Elderly with Dementia

    Jun 1, 2015, 00:00

  • Assessing the Health-Related Quality of Life of Australian Adolescents- An Empirical Comparison of the Child Health Utility 9D and EQ-5D-Y Instruments

    Jun 1, 2015, 00:00

  • Assessment of the Quality of the Clinical Evidence in Submissions to the Australian Pharmaceutical Benefits Advisory Committee- Fit for Purpose?

    Jun 1, 2015, 00:00

  • Table of Contents

    Jun 1, 2015, 00:00

  • Decision-Oriented Health Technology Assessment- One Step Forward in Supporting the Decision-Making Process in Hospitals

    Jun 1, 2015, 00:00

  • The Value Adults Place on Child Health and Functional Status

    Jun 1, 2015, 00:00

  • Modeling Health State Utility Values in Ankylosing Spondylitis- Comparisons of Direct and Indirect Methods

    Jun 1, 2015, 00:00

  • Erratum

    Jun 1, 2015, 00:00

  • Methods for Developing Patient-Reported Outcome-Based Performance Measures (PRO-PMs)

    Jun 1, 2015, 00:00

  • Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States- A Disease Transmission Dynamic Modeling Approach

    Jun 1, 2015, 00:00

  • Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian Cancer

    Jun 1, 2015, 00:00

  • Evaluation of Neuropsychiatric Function in Phenylketonuria- Psychometric Properties of the ADHD Rating Scale-IV and Adult ADHD Self-Report Scale Inattention Subscale in Phenylketonuria

    Jun 1, 2015, 00:00

  • Do Probability and Certainty Equivalent Techniques Lead to Inconsistent Results? Evidence from Gambles Involving Life-Years and Quality of Life

    Jun 1, 2015, 00:00

  • Results Of An Intervention In Prescription Of Conventional Release Verapamil In Patients With Hypertension In Colombia

    May 1, 2015, 00:00

  • THE ASSOCIATION BETWEEN ADHERENCE TO CARDIOVASCULAR MEDICATIONS AND HEALTH CARE UTILIZATION

    May 1, 2015, 00:00

  • An Evaluation Of The Use Of Antibiotics In A Teaching Hospital In Bahawalpur

    May 1, 2015, 00:00

  • Cost-Minimization Analysis of Tinzaparin Sodium Compared to Other Low-Molecular-Weight Heparins for Patients With Deep Venous Thrombosis

    May 1, 2015, 00:00

  • Explaining The Excess Home Health Care Use And Expenditures Among Elderly Medicare Beneficiaries With Parkinson’s Disease

    May 1, 2015, 00:00

  • Assessment of a french Endocrinologist electronic medical Record database for use In observational Studies

    May 1, 2015, 00:00

  • Risk of Cardiotoxicity And All-Cause Mortality In Breast Cancer Patients After Adjuvant Chemotherapy or Hormonal Therapy

    May 1, 2015, 00:00

  • A Vision ‘Bolt-On’ item increased the sensitivity of EQ-5D in a cross-sectional Health Survey

    May 1, 2015, 00:00

  • Patterns of treatment modifications in newly treated hypertensive patients- does choice of modification strategy affect likelihood of treatment discontinuation?

    May 1, 2015, 00:00

  • TREATMENT PATTERNS OF MONOTHERAPY VERSUS COMBINATION ANTIEPILEPTIC DRUG THERAPY IN PATIENTS WITH EPILEPSY

    May 1, 2015, 00:00

  • Physician care-providing Behavior in treating Attention-Deficit Hyperactive Children and Adolescents

    May 1, 2015, 00:00

  • Caregivers’ preferences for treatment options in Attention Deficit Hyperactivity Disorder (ADHD)- a latent class analysis

    May 1, 2015, 00:00

  • The Cost-effectiveness of canagliflozin (Cana) versus Saxagliptin (Saxa) among older Individuals living with type 2 diabetes mellitus (T2dm) In canada

    May 1, 2015, 00:00

  • Mortality and rehospitalization rates among hospitalized pneumonia patients in the u.s. Medicare population

    May 1, 2015, 00:00

  • Safety pen needle (SPN) devices in the actue care setting- an analysis of health resource utilization (HRU) in the United States

    May 1, 2015, 00:00

  • The Amelioration of doxorubicin-induced oxidative Liver Injury by Ursodeoxycholic Acid

    May 1, 2015, 00:00

  • Content Validity Evaluation of A New Diary Developed to Evaluate Symptoms Important to Patients With Moderate to Severe Rheumatoid Arthritis

    May 1, 2015, 00:00

  • Systematic review of qualitative studies to identify Health related quality of life constructs reported by patients with Hepatitis C

    May 1, 2015, 00:00

  • Pattern of Adjunctive Drug Utilization in oncology Department

    May 1, 2015, 00:00

  • An Economic Evaluation of Ranibizumab versus Aflibercept for the treatment of Neovascular (WET) AMD in the United Kingdom

    May 1, 2015, 00:00

  • Cost/Utility analysis of Pneumococcal Vaccinees Pcv13 Versus Ppsv23 In Adults over 18 Years old in chile

    May 1, 2015, 00:00

  • Antidepressant use in patients with age-related Macular degeneration and depressive symptoms- baseline results from the low vision depression prevention trial

    May 1, 2015, 00:00

  • Evidence Requirements For Future Antiarrhythmic Treatments For Atrial Fibrillation (Af)

    May 1, 2015, 00:00

  • Outcomes, Health Costs And Use Of Statins In 6,226 Patients Admitted In 2011 For An Acute Coronary Syndrome (Acs) Occurring In A Large Community Setting Of 2,989,512 Subjects

    May 1, 2015, 00:00

  • Do different modeling techniques change rankings of hospital performance? - multilevel modeling vs. Standard logistic regression

    May 1, 2015, 00:00

  • Use of Hydrocodone/Acetaminophen- prevalence and estimating Emergency Department visits

    May 1, 2015, 00:00

  • One-Year Cost Outcomes of Early Physical Therapy (PT) Compared With A Usual Care Approach For Patients With Acute Low Back Pain (LBP) Consulting Primary Care

    May 1, 2015, 00:00

  • Medical resource Utilization of acute Myocardial infarction patients with readmission- a retrospective analysis of Hospitalization data from Beijing Medical Insurance database

    May 1, 2015, 00:00

  • Cost-Effectiveness of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Canada, Sweden And The Uk

    May 1, 2015, 00:00

  • Treatment Satisfaction Among Patients treated with Monotherapy And Adjunctive Antiepileptic Drug Therapies

    May 1, 2015, 00:00

  • Patient Preferences For Palliative Treatment of Locally Advanced or Metastatic Gastric Cancer and Adenocarcinoma of the Gastrooesophageal Junction- a Choice-Based Conjoint Analysis Study From Germany

    May 1, 2015, 00:00

  • Psychometric validation of the Dysphagia Symptom questionnaire in Eosinophilic Esophagitis patients treated with Oral Budesonide Suspension

    May 1, 2015, 00:00

  • Barbec(EU)d Oncology market access – how BBQ pulled pork is similar to European PR Negotiations

    May 1, 2015, 00:00

  • Treatment for Chemotherapy-Related Cognitive Dysfunction- Review of The Literature

    May 1, 2015, 00:00

  • Factors and Reasons Associated With Switching In Rheumatoid Arthritis Patients Newly Initiated On Biologic Dmards And Impact on Health Care Resource Utilization In a Managed Care organization

    May 1, 2015, 00:00

  • Time Until Insulin Initiation for Canagliflozin (Cana) versus Dapagliflozin (Dapa) In dual and triple Therapy for type 2 diabetes mellitus (T2dm) In Ireland

    May 1, 2015, 00:00

  • Functional Status Among Patients With Rheumatic Diseases In The Slovak Republic

    May 1, 2015, 00:00

  • Sleep Medication Users and their Characteristics

    May 1, 2015, 00:00

  • Antipsychotic use and Foster Care placement stability among youth with Attention-Deficit Hyperactivity/Disruptive Behavior Disorders

    May 1, 2015, 00:00

  • Injection frequency and costs of Anti-Vegf treatments for Neovascular age-related Macular Degeneration, Retinal Vein Occlusion, and Diabetic Macular Edema

    May 1, 2015, 00:00

  • Universal Versus Targeted Screening of colon Cancers for Lynch Syndrome- Cost and Diagnostic Effectiveness Analyses Based on Clinical Experience

    May 1, 2015, 00:00

  • Adjusting overall Survival Estimates for Treatment Switching- a Case Study in Metastatic Castration-Resistant Prostate Cancer

    May 1, 2015, 00:00

  • Comparative Effectiveness Research (CER) and its effect on the Health Care decision-making Environment

    May 1, 2015, 00:00

  • Qualitative study of Patients’ preferences for Bipolar Depression Treatment

    May 1, 2015, 00:00

  • Ribavirin does not impact health-related quality of life (HRQOL) in patients on Ombitasvir/ Paritaprevir /Ritonavir and dasabuvir at the end of 12-week treatment in Treatment-NaÏve adults with Genotype 1A (GT1A) Chronic Hepatitis C

    May 1, 2015, 00:00

  • Reducing maternal and Child Mortality in Ghana- is National Health Insurance scheme’s free maternal care programme helping?

    May 1, 2015, 00:00

  • Effect of Daily or weekly Glp-1 receptor Agonists on glycemic Control In Insulin-NaÏVe patients With Poorly Controlled type 2 Diabetes- a real-world study

    May 1, 2015, 00:00

  • “Cost Of Illness” Analysis Of Chronic Kidney Disease In The Entire Population Of The Russian Federation

    May 1, 2015, 00:00

  • Association Between Osteoarthritis and Workplace Absenteeism

    May 1, 2015, 00:00

  • Medication use patterns, Health-care resource Utilization and Economic burden for patients with Schizophrenia in Beijing, China

    May 1, 2015, 00:00
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88 (current)
  • 89
  • 90
  • »